Aquatic Capital Management LLC Allogene Therapeutics, Inc. Transaction History

Aquatic Capital Management LLC

  • $3.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$5.62 - $11.11 $151,178 - $298,859
-26,900 Reduced 33.63%
53,100 $334,000
Q3 2022

Nov 14, 2022
BUY
$10.32 - $17.28 $825,600 - $1.38 Million
80,000 New
80,000 $864,000
Q2 2022

Aug 15, 2022
SELL
$6.78 - $12.28 $25,086 - $45,436
-3,700 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$7.65 - $15.29 $28,305 - $56,573
3,700 New
3,700 $34,000

Others Institutions Holding ALLO

# of Institutions
162
Shares Held
134M
Call Options Held
59.4K
Put Options Held
113K
View Full List

About Allogene Therapeutics, Inc.

ALLO Quotes by TradingView
  • Ticker ALLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,807,008
  • Market Cap $326M
  • Description
  • Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...
More about ALLO
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email